Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza Virus Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00833885
What this trial is testing

Tolerability and Measurability of the Efficacy of Non Pharmaceutical Measures to Prevent Seasonal Influenza

Who this might be right for
Influenza
Robert Koch Institut 300
Not applicableStudy completedNCT06095947
What this trial is testing

Exploration on the Quadrivalent Influenza Vaccine Immunization Schedule for Children Aged 3-8 Years

Who this might be right for
GCP
Hualan Biological Bacterin Co. Ltd. 652
Not applicableUnknownNCT04716543
What this trial is testing

Epidemiological Investigation of COVID-19 in Laos Using a One-Health Approach in Human and Animals

Who this might be right for
Influenza -Like IllnessCovid19
ANRS, Emerging Infectious Diseases 5,400
Large-scale testing (Phase 3)Study completedNCT00881842
What this trial is testing

Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 09/10 Season

Who this might be right for
Influenza
Abbott Biologicals 120
Large-scale testing (Phase 3)Study completedNCT00707941
What this trial is testing

Oseltamivir Randomised Controlled Efficacy Trial

Who this might be right for
InfluenzaPneumoniaLower Respiratory Tract Infection+2 more
International Centre for Diarrhoeal Disease Research, Bangladesh 1,190
Early research (Phase 1)Study completedNCT00814229
What this trial is testing

Safety and Immunogenicity of Influenza H9 Vaccine in Humans

Who this might be right for
Influenza
University Hospitals, Leicester 353
Not applicableStudy completedNCT05537441
What this trial is testing

Precision Vaccine Promotion in Underserved Populations

Who this might be right for
InfluenzaVaccine Hesitancy
University of Southern California 228,831
Post-approval studies (Phase 4)Study completedNCT02915302
What this trial is testing

Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 1,950
Large-scale testing (Phase 3)Study completedNCT00259831
What this trial is testing

Efficacy of Cold-FX (CVT-E002) in the Prevention of Upper Respiratory Tract Infections in Healthy Adults

Who this might be right for
Upper Respiratory Infection
CV Technologies 500
Large-scale testing (Phase 3)Not Yet RecruitingNCT07730346
What this trial is testing

Study to Assess the Prophylactic Efficacy and Safety of Sebaloxavir Marboxil Tablets/Oral Suspension for Influenza Prevention in Household Contacts Aged ≥2 Years.

Who this might be right for
Influenza Prevention
Nanjing Zenshine Pharmaceuticals 858
Not applicableEnrolling By InvitationNCT07651761
What this trial is testing

Patient-Centered Practical Vaccine Talk For Busy Clinicians

Who this might be right for
InfluenzaCOVID-19
University of Massachusetts, Worcester 24,500
Post-approval studies (Phase 4)Study completedNCT01079273
What this trial is testing

Clinical Study to Evaluate Antibody and Cell Mediated Immunity of A/H1N1 Influenza Vaccine in Healthy Subjects

Who this might be right for
Influenza
Opera CRO, a TIGERMED Group Company 7
Large-scale testing (Phase 3)Looking for participantsNCT07604103
What this trial is testing

Analysis of Growth Differentiation Factor 15 (GDF-15), Mid Regional proAdrenomedullin (MR proADM), and Persepsin Levels in Patient in Acute Coronary Syndrome Patients With Pneumonia, With or Without Influenza Vaccination

Who this might be right for
Acute Coronary Syndromes (ACS)PneumoniaCOPD (Chronic Obstructive Pulmonary Disease)
University of Brawijaya 60
Post-approval studies (Phase 4)Study completedNCT00561002
What this trial is testing

Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone® Vaccine

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 34
Early research (Phase 1)Study completedNCT05875961
What this trial is testing

Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults

Who this might be right for
Influenza, HumanInfectionsRespiratory Tract Infections+2 more
Seqirus 600
Early research (Phase 1)Study completedNCT05829356
What this trial is testing

Substudy 01 - Safety and Immunogenicity of One Monovalent Modified mRNA Vaccine Encoding Influenza Hemagglutinin With LNP, in Adult Participants Aged 18 to 49 Years and 60 Years and Above

Who this might be right for
Influenza Immunization
Sanofi Pasteur, a Sanofi Company 159
Testing effectiveness (Phase 2)Study completedNCT03845231
What this trial is testing

Mucosal and Systemic Immunity After Viral Challenge of Healthy Volunteers Vaccinated With Inactivated Influenza Vaccine Via the Intranasal Versus Intramuscular Route

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 82
Large-scale testing (Phase 3)Study completedNCT00782431
What this trial is testing

Immunogenicity and Safety Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) in Adults Aged 50 Years and Older

Who this might be right for
Influenza
Alachua Government Services, Inc. 3,208
Large-scale testing (Phase 3)Not Yet RecruitingNCT07133802
What this trial is testing

Clinical Trial to Evaluate the Protective Efficacy and Safety of a Nasal Spray Live Attenuated Influenza Vaccine (LAIV) in Adults Aged 18-59 Years Post-Vaccination

Who this might be right for
Prevention of Influenza
Changchun BCHT Biotechnology Co. 6,680
Testing effectiveness (Phase 2)Study completedNCT00841646
What this trial is testing

Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects

Who this might be right for
Prepandemic Influenza Vaccine
Novartis Vaccines 343
Next Page